Clinical Research Studies

GSK3228836 (the study drug) is an experimental new drug for treating chronic hepatitis B (CHB) and is not approved by the United States Food and Drug Administration (FDA) for use in people living with CHB. CHB is caused by the hepatitis B virus, which infects the liver and can cause damage. Most people who become infected as an adult with the virus get rid of it without any problems. People who become infected as a child may be more likely to develop chronic infection. In some people, the immune system (which helps your body protect you from getting sick) is unable to get rid of the hepatitis B virus and this results in lifelong infection that can cause serious liver disease.